Physitrack

7.96 SEK

+2.58%

Less than 1K followers

PTRK

First North Stockholm

Software

Technology

+2.58 %
-14.78 %
-26.64 %
-39.24 %
-43.35 %
-30.78 %
-59.07 %
-
-82.88 %

Physitrack operates in the healthcare sector and specializes in physiotherapy. The product portfolio includes digital healthcare offerings for companies via SaaS solutions. In addition to the main business, personal service and related ancillary services are also offered. The business is operated globally with the largest presence in Europe and North America. Physitrack was founded in 2012 and is headquartered in London.

Read more
Market cap
129.44M SEK
Turnover
131.14K SEK
Revenue
146.05M
EBIT %
-45.34 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26.6
2026

General meeting '26

21.7
2026

Interim report Q2'26

20.10
2026

Interim report Q3'26

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Forum discussions
Stable storage.mfn.se q1-2026-interim-report-v1.pdf Summary for the period First quarter: 1 January – 31 March 2026 Based on Alternative Key Performance Measures, the Company’s key financial highlights for the period are summarised below. Constant currency revenue amounted to EUR...
True, it’s stable. Fortunately, we are slowly drifting forward anyway. I’d prefer to see slightly stronger figures before the US listings. By the way, we’ve drifted quite close to Redeye’s bear case again: Physitrack - Redeye Are there any other analysts still covering this?
Permission received from the lender to start the program Physitrack PLC receives lender consent for share buyback program Physitrack PLC (Nasdaq First North: PTRK) (“Physitrack” or the “Company”) today announces that it has received the necessary consent from its banking partner ...
US market is open While not significant in value, the signal value for the future is very good. Physitrack signs Agreement with New York-based Academic Medical Center Physitrack PLC (Nasdaq First North Premier: PTRK) — New Commercial Agreement Generates $100,556 in Total Contract...
I would hope for more deals on the wellness side so that its competitiveness and demand would be proven. This will do for now while waiting for those Physitrack announces agreement with leading Swiss healthcare organisation Physitrack PLC (Nasdaq First North Premier: PTRK) has reached...
A Q4 update fairly in line with expectations. Official and audited figures will follow later. Growth is needed; profitability is significantly better. storage.mfn.se pdf-report-physitrack-plc-unaudited-fy2025-trading-update-and-preliminary-results.pdf CEO Henrik’s interview https...
Redeye’s more extensive comments redeye.se Physitrack (Q3 Review): Staying on track with solid profitability and cash flow Redeye has updated its estimates following Physitrack’s Q3 2025 report, which was broadly in line with expectations. The quarter showed continued margin strength...
Read more on our forum